-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4277.0
- ISIN : INE307N01014
-
Today’s Low
77.50 -
Today’s High
80.46
-
Open
80.11 -
Perv Close
81.28 -
52W Low
60.45 -
52W High
103.20
Key Indicators
-
P/E(TTM)
42.71
-
Mar.Cap (₹Cr.)
346.06
-
Div & Yield %
0.00
-
Book Value(₹)
76.14
-
Debt-Equity Ratio
-2.79
-
AGM Date
22-Jul-2026
-
EPS
1.85
-
P/E Ratio
42.71
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
346.06
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
43.80
-
BV (₹)
76.10
-
Sales( ₹ in Cr.)
156.00
-
NP (in Cr.)
8.12
-
NP Var(%)
-9.0
-
Div%
0.0
-
CPS (₹)
2.00
-
EPS (₹)
1.90
-
Traded Value (₹ in Lakhs)
346.06
-
52 Week High
103.20
-
52 Week Low
60.45
-
Price BSE
79.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
346.06
-
P/C Ratio
39.30
-
P/E Ratio
42.60
-
Price Vs.BV
1.90
-
01-Jun-2026( 04:20)
Results - Announcements - Astal... - Net profit of Astal Laboratori...
-
26-May-2026( 01:59)
Corporate News - Astal... - Astal Laboratories will hold...
-
15-Feb-2026( 09:41)
Results - Announcements - Astal... - Net profit of Astal Laboratori...
-
11-Feb-2026( 10:22)
Corporate News - Astal... - Astal Laboratories will hold...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 64.23 | 23.65 | 3.43 | 0.00 | 0.20 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 64.23 | 23.65 | 3.43 | 0.00 | 0.20 | 0.00 |
| Other Income | 0.13 | 0.01 | 0.18 | 0.21 | 0.00 | 0.20 |
| Stock Adjustments | 13.70 | 1.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 78.06 | 24.72 | 3.61 | 0.21 | 0.20 | 0.20 |
| EXPENDITURE : | ||||||
| Raw Materials | 61.81 | 22.40 | 3.35 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.14 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 |
| Employee Cost | 1.26 | 0.47 | 0.06 | 0.09 | 0.06 | 0.09 |
| Other Manufacturing Expenses | 0.37 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Selling and Administration Expenses | 1.57 | 0.71 | 0.13 | 0.10 | 0.10 | 0.10 |
| Miscellaneous Expenses | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Employee Benefit Expenses | 1.26 | 0.47 | 0.06 | 0.09 | 0.06 | 0.09 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 65.15 | 23.59 | 3.56 | 0.21 | 0.18 | 0.22 |
| Operating Profit | 12.90 | 1.13 | 0.04 | 0.00 | 0.02 | -0.01 |
| Interest | 0.70 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 12.20 | 1.12 | 0.04 | 0.00 | 0.02 | -0.01 |
| Depreciation | 0.22 | 0.03 | 0.01 | 0.01 | 0.02 | 0.02 |
| Profit Before Tax | 11.98 | 1.09 | 0.03 | -0.01 | 0.00 | -0.03 |
| Current Tax | 2.94 | 0.29 | 0.01 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.11 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 8.93 | 0.78 | 0.02 | -0.02 | 0.01 | -0.03 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 8.93 | 0.78 | 0.02 | -0.02 | 0.01 | -0.03 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 1.78 | 0.99 | 0.98 | 0.99 | 0.99 | 1.02 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 10.70 | 1.78 | 0.99 | 0.98 | 0.99 | 0.99 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 9.07 | 0.80 | 0.04 | -0.04 | 0.02 | -0.07 |
| Earnings Per Share(Adj)-Unit Curr | 9.07 | 0.80 | 0.04 | -0.04 | 0.02 | - |
| Book Value | 32.77 | 23.71 | 12.98 | 12.93 | 12.97 | 12.96 |
| Book Value(Adj)-Unit Curr | 32.77 | 23.71 | 12.98 | 12.93 | 12.97 | - |
